Circulating beta-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction

31 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Emerging insights in acute coronary syndrome: biomarkers, non-traditional risk factors, and clinical outcomes ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology